| 1.40 Data as of Jun 19 |  -0.05 / -3.45%Today’s Change | 1.00 Today|||52-Week Range 7.10 | -39.39% Year-to-Date |
| Previous close | 1.45 |
| Today’s open | 1.45 |
| Day’s range | 1.37 - 1.47 |
| Volume | 337,146 |
| Average volume (3 months) | 187,818 |
| Market cap | $40.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -18.00% |
| Earnings growth (this year) | +34.96% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +72.28% |
| P/E ratio | NM |
| Price/Sales | 16.59 |
| Price/Book | 96.28 |
| Today’s change | Today’s % change | |
|---|---|---|
| HSKAHeska Corp | -0.01 | -0.14% |
| CPRXCatalyst Pharmaceuti... | -0.04 | -3.70% |
| HEBHemispherx Biopharma... | -0.00 | -1.52% |
| MSTXMast Therapeutics In... | +0.01 | +2.27% |
| Next reporting date | August 15, 2013 |
| EPS forecast (this quarter) | -$0.20 |
| Annual revenue (last year) | $2.8M |
| Annual profit (last year) | -$23.8M |
| Net profit margin | -844.37% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Paul R. Sohmer, MD |
Senior VP-Executive Operations & Human Resources Anastasia Rader |
Corporate headquarters Waltham, Massachusetts |
.
